Detected ·
Beacon Biosignals
——
Beacon Biosignals announced an extension of its Series B to $97.2 million, bringing total funding above $132 million. New investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next joined the round.
- Website
- beacon.bio
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-07 12:03:50 UTC
- Signal ID
- 6316eebe-7db9-4190-b6fe-c1fc3821b833
As the API returns it
{
"id": "6316eebe-7db9-4190-b6fe-c1fc3821b833",
"created_at": "2026-04-07T12:03:50.761651Z",
"company_name": "Beacon Biosignals",
"company_website_url": "beacon.bio",
"company_linkedin_url": "https://www.linkedin.com/company/beaconbiosignals",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Beacon Biosignals announced an extension of its Series B to $97.2 million, bringing total funding above $132 million. New investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next joined the round.*"
}